Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...

How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Imagine the market is like a massive rubber band. When stretched too far in one direction, it must inevitably snap back, or retrace, before moving forward again. The challenge for the individual ...

For active investors, the challenge is not typically finding a good stock or an entry point; it’s knowing where to get out. When a stock surges past its previous high, you enter what technical ...

Gwendolyn “Blondy” Chisolm, the rapper and singer-songwriter who co-founded the Sequence, has died, Rolling Stone has confirmed. She was 66. Chisolm formed the hip-hip group with Cheryl “The Pearl” ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

An article in the June issue (Nat. Biotechnol. 22, 773–774, 2004) highlights the challenge of producing a shared vocabulary that biologists can use to communicate their results effectively, explore ...